Outcome of Board Meeting

July 31, 2026 To, To, National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, BKC P.J. Towers, Bandra-Kurla Complex, 25th Floor, Dalal Street, Fort Bandra (East), Mumbai-400 051 Mumbai 400 001 Symbol: JLHL Code: 543980 Subject: Outcome of the Board Meeting held on Friday, July 31, 2026 Dear Sir/Madam, In furtherance to our intimation dated July 27, 2026, this is to inform you that pursuant to Regulations 30, 33, and Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”), the Board of Directors of the Company at its Meeting held today, i.e., July 31, 2026, has inter-alia:- a) Considered and approved the Unaudited Financial Results (both standalone and consolidated basis) for the quarter ended on June 30, 2026 along with the Limited Review Report. A copy of the said Results is enclosed herewith as Annexure – I. b) Considered and approved the appointment of Mr. Harshad Purani as the Chief Financial officer and Key Managerial Personnel of the company with effect from July 31, 2026. The details as required in terms of SEBI Listing Regulations and SEBI Master Circular dated January 31, 2026 are enclosed herewith as Annexure – II. c) Taken on record that Jupiter Hospital Pharmacy Private Limited (JHPPL), a subsidiary of the Company, has acquired 100% of the equity share capital of Sulcus Private Limited (“Sulcus”) for a consideration of ₹3.78 crore. Consequently, Sulcus has become a wholly owned subsidiary of JHPPL and a step-down subsidiary of the Company. The details as required in terms of Listing Regulations and SEBI Master Circular dated January 31, 2026 are enclosed herewith as Annexure – III and Annexure IV. The Board meeting commenced at 3:00 P.M. and was conclude at 3.45 P.M. The aforementioned information will be available at the website of the Company at www.jupiterhospital.com. You are requested to kindly take the afore mentioned on record and oblige. Thanking you, For JUPITER LIFE LINE HOSPITALS LIMITED Suma Upparatti Company Secretary & Compliance Officer Encl : As stated above Annexure I KKC & Asso(iates LLP Aswin P, Matde & Co, Chartered Accountants Chartered Accountants (formerly Khimji Kunverji & Co LLP) Su nshine Tower, LeveL 19 405, Jay Commercial Plaza, Senapati Bapat Marg Junction ofS.L. Road & M.G, Road, Elphinstone Road Mutund (W), Mumbai '400 013 Mumbai - 400 080 Telephone: +91 22 6L437333 Telephone: 65525689 lndependent Auditor's Review Report on unaudited standalone financial results for the quarter ended 30 June 2026 of Jupiter Life Line Hospitals Limited under Regulation 33 of the SEBI (Listing Obligations and Disctosure Requirements) Regulations, 2015, as amended. The Board of Directors of Jupiter Life Line Hospitals Limited lntroduction We have reviewed the accompanying statement of unaudited standalone financiaI resuLts of Jupiter Life Line Hospitals Limited ('the Company') forthe quarterended 30 Ju ne 2026 ('the Statement'), being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of lndia (Listing Obligations and Disctosure Requirements) Regulations, 2015, as amended ('Listing Regutations'). We have initiatled the Statement for identification purpose only. This Statement, which is the responsibility of the Com pany's N4anagement and approved by the Boa rd of Directors ofthe Company, has been prepared in accordance with the recognition and measurement principles laid down in the lndian Accounting Standard ('lnd AS') 34'lnterim FinanciaI Reporting' specified in section 133 of the Companies Act, 2013 ('the Act'), read with relevant rutes issued thereunder and other accounting principLes generally accepted in lndia and in compliance with Regu lation 33 of the Listing Regu lations. Ou r responsibility is to express a conclusion on the Statement based on our review. Scope of Review We conducted our review of the Statement in accordance with the Standard on Review Engagements ('SRE') 2410 -'Review of lnterim Financial lnformation Performed by the lndependent Auditor of the Entity' issued by the lnstitute of Chartered Accountants of lndia ('the lCAl'). This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review is limited primarily to inqu iries of compa ny's person net a nd analytica I procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingty, we do not express an aud it opinion. Conclusion Based on our review conducted as above, nothing has come to our attention that causes us to betieve that the accompanying Statement, prepared in accordance with the recognition and measurement principtes laid down in lnd AS, specified u nder Section 133 of the Act as amended, read with relevant rutes issued thereunder and other accounting principles generally accepted in lndia has not disclosed Cha.t€red o q M' No. lccq alb b 0!2662 $ MUMBAI Page I of 2 KKC & Asso6iates LLP Aswin P. Malde & Co. Chartered Accountants Chartered Accountants (formerty Khimji Kunverji & Co LLP) Su nshine Tower, Level 19 405, Jay Commercial Plaza, Sena pati Bapat Marg Junction of S.L. Road & lvl.G, Road, Elphinstone Road Ir4 u tu nd (W), Mumbai - 400 013 Mumbai - 400 080 Telephone: +91 22 61437333 Telephone: 65525689 the information required to be disctosed in terms of Regulation 33 of the Listing Regutations, includ ing the manner in which it is to be disctosed, orthat it contains any materiat misstatement. Other Matter 5. Attention is d rawn to the fact that the figu res for the quarter ended 31 March 2026 as reported in these financial resutts a re the ba lancing figures between audited figu res in respect of the futl previous financial year and the published unaudited year to date figures up to the third quarter of the previous financial year. The figu res u p to the end of the third q uarter of previous financial year had on ly been reviewed and not su bjected to audit. 6. The Standalone financiat results inctude the financial information of 1 (one) partnership firm whose financial information being certified by the Management, reflects the Company's share of net loss after tax of Rs. 3.24 miltion for the quarter ended 30 June 2025, as considered in the Statement. According to the information and explanations given to us by the Management, this financial information are not material to the Company. Ourconclusion is not modified in respect of these matters. For KKC & Associates LLP For Aswin P. Malde & Co, Chartered Accou ntants Chartered Accountants (formerly Khimji Kunverji & Co LLP) Firm Registration Number: 105146WW100621 rm Registration Number: 100725W Hasmukh B Dedhia Aswin P. Malde o C a M. NO' Partner Proprietor 0!2662 rfl lCAl Membership No: 33494 o c arlered lCAl Membership No: 032662 MUMBAI uDtN:2 6 03 3r{q qYEFr€K56sl Accountanls b U DIN: Place: l\4umbai Place: Mumbai Date: 31 J uly 2026 Date: 31 Ju ly 2026 UDIN 1 26 o 32-6 6 21? 5 7 qi I SqL Page 2 of 2 JUPITER LIFE LINE HOSPITAI-5 LIMITED CIN: 185100ivlH2002PtC137908 legistered Offi.e: 1004, 10th floor,'360 Degree Eusiness Park', Maharana Pratap Chowk, LBS Marg, Mulund (W), Mumbai, Maharashtra . 400 08( Corporate Office: Eastern Express Hi8hway, Thane (W), Maharashtra - 40O 601 Telephone No:022 52976530 Email: info@jupiterhospital-com Webr www.jupiterhospital.com STATEMENT OF UNAUDITEO STANDAI.ONE FINANCIAI. RESUI-TS FOR THE QUARTER INDED JUNE 30, 2026 Quarter Ended 5t. No Pa.ticulars ,une 30,2026 March 31, 2026 lune 30,2025 March 31, 2025 Unaudited (Refer Note 5) Unaudited 1 lnaome Revenue from opeaations 3,284.85 3,124.21 2,119.87 77,916.24 b Other income 106.43 89.46 128.36 422.57 Totallnaome 3,391.28 3,213.69 2,904.23 1:,398.75 2 Expeniei a Purchases of medical consumables. drugs and surgical item! 588.93 597.19 511.33 2,236.18 b Changes in inventories of medical consumables, drugs and 7.36 {42 [Showing first 8,000 characters — download PDF for full document]